COMPLAINT REPORTING. CPP shall have responsibility for reporting any complaints relating to Products to the Regulatory Authorities in the Territory, including, but not limited to, complaints relating to the manufacture of Products as well as adverse drug experience reports. At CPP’s request and upon reasonable notice, sanofi-aventis shall provide CPP with information and records in its possession or control concerning the manufacturing for such Product that is the subject of the complaint.
Appears in 2 contracts
Sources: Product Manufacturing & Supply Agreement (Cancer Prevention Pharmaceuticals, Inc.), Product Manufacturing & Supply Agreement (Cancer Prevention Pharmaceuticals, Inc.)